Combined treatment with an AT1 receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress.

Source:http://linkedlifedata.com/resource/pubmed/id/15005276

Download in:

View as

General Info

PMID
15005276